Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Brandt-Rauf

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|October 24, 2006
Plasma-transforming growth factor-alpha expression in residents of an arseniasis area in TaiwanK-H Hsu, P Brandt-Rauf, T-M Lin, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1997
Selective inhibition of oncogenic ras-p21 in vivo by agents that block its interaction with jun-N-kinase (JNK) and jun proteins. Implications for the design of selective chemotherapeutic agentsS Amar, A Glozman, D Chung, et al.
Journal of Occupational and Environmental Medicine|December 28, 2000
Associations between drinking water and urinary arsenic levels and skin lesions in BangladeshH Ahsan, M Perrin, A Rahman, et al.
Journal of Protein Chemistry|August 1, 1997
Inhibition of oncogenic and activated wild-type ras-p21 protein-induced oocyte maturation by peptides from the ras-binding domain of the raf-p74 protein, identified from molecular dynamics calculationsD Chung, S Amar, A Glozman, et al.
Nature|November 19, 1992
Molecular and genetic damage in humans from environmental pollution in PolandF P Perera, K Hemminki, E Gryzbowska, et al.
Archives of Toxicology|January 1, 1990
Protein binding, sister chromatid exchange and expression of oncogene proteins in patients treated with cisplatinum (cisDDP)-based chemotherapyF Perera, H K Fischman, K Hemminki, et al.
Environmental Health Perspectives|January 1, 1994
Chlorinated and brominated dioxins and dibenzofurans in human tissue following exposureA Schecter, J J Ryan, Y Masuda, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|October 24, 2006
Plasma-transforming growth factor-alpha expression in residents of an arseniasis area in TaiwanK-H Hsu, P Brandt-Rauf, T-M Lin, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1997
Selective inhibition of oncogenic ras-p21 in vivo by agents that block its interaction with jun-N-kinase (JNK) and jun proteins. Implications for the design of selective chemotherapeutic agentsS Amar, A Glozman, D Chung, et al.
Journal of Occupational and Environmental Medicine|December 28, 2000
Associations between drinking water and urinary arsenic levels and skin lesions in BangladeshH Ahsan, M Perrin, A Rahman, et al.
Journal of Protein Chemistry|August 1, 1997
Inhibition of oncogenic and activated wild-type ras-p21 protein-induced oocyte maturation by peptides from the ras-binding domain of the raf-p74 protein, identified from molecular dynamics calculationsD Chung, S Amar, A Glozman, et al.
Nature|November 19, 1992
Molecular and genetic damage in humans from environmental pollution in PolandF P Perera, K Hemminki, E Gryzbowska, et al.
Archives of Toxicology|January 1, 1990
Protein binding, sister chromatid exchange and expression of oncogene proteins in patients treated with cisplatinum (cisDDP)-based chemotherapyF Perera, H K Fischman, K Hemminki, et al.
Environmental Health Perspectives|January 1, 1994
Chlorinated and brominated dioxins and dibenzofurans in human tissue following exposureA Schecter, J J Ryan, Y Masuda, et al.
Pageof 3